We should have enough cash to fund a phase1 aurora ourselves. There could be an issue of shares to a strategic partnership who wants a program. But then the sp will jump after. We could also buy back any rights Sri have in tyk 2. But guess that would only be less than 500 grand (repay the grants they received). They could acquire an external program. (Onco virus perhaps). My preference would be for us to fund tyk2 in cancer all the way. The trials will be small. Relatively cheap. Fast track and orphan and we could be on sale in 3 years. 4000 patients p.a. 100k per year. 400m pa revenue stream. But we don't know. Guesswork. Those who trade will trade. Those who invest are much richer than 6 months ago. Roll on sareum with the excellent progress and research finally becoming commercialised.
He will know, he knows everything, top Trader, in that Walter Mitty World he lives in. Good Traders don't come on here to Spout garbage. They have more than 1 Computer with Software setup, now run along Walter it's Bedtime and don't forget your Dummy. TopTrader my ass. 😂
Datafeed and UK data supplied by NBTrader and Digital Look.
While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.